Facebook
Twitter
LinkedIn
ForwardEmergency Medicine Critical Care Transport (EMCCT) Continuing Education 2022
The UW Health Critical Care Transport (CCT) Education is a multidisciplinary team comprised of nurses, respiratory therapists, physicians, communication specialists, and program leadership. We are committed to providing quality education curriculum that satisfies the education requirements set forth by UW Health policy, and the Commission on Accreditation of Medical Transport Systems (CAMTS). These requirements are satisfied with a multi-faceted approach utilizing didactic education, computer-based training, simulation, and clinical experiences.
ELEMENTS OF COMPETENCE
This continuing education (CE) activity has been designed to change learner competence and performance, and focuses on the American Board of Medical Specialties areas of patient care and procedural skills, practice-based learning and improvement, interpersonal and communication skills, and systems-based practice, in addition to the interprofessional competencies of communication, roles/responsibilities, and teams/teamwork.
Intended Audience
This activity is designed for physicians and nurses practicing in the critical care transport environment.
Learning Objectives
By participating in these activities the EMCCT team and its members will be able to:
- Formulate patient-care decisions based on established team workflows.
- Identify EMCCT members' roles and responsibilities and how they may change in various CCT situations.
- Summarize current technology and best practices in the UW CCT program.
Please see individual sessions for program information.
POLICY ON DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by, or on, patients.
The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
| NAME | ROLE(S) | FINANCIAL RELATIONSHIPS DISCLOSURE | DISCUSSION OF UNLABELED/UNAPPROVED USES OF DRUGS/DEVICES IN PRESENTATION? |
| Brittney Bernardoni, MD | Committee Member, Speaker | No relevant relationships with ineligible companies to disclose | No |
| Peter Borkowski, RN | Speaker | No relevant relationships with ineligible companies to disclose | No |
| Andrew Cathers, MD | Committee Member, Medical Director, Speaker | No relevant relationships with ineligible companies to disclose | No |
| Taylor Johnson, MBA | Committee Member | No relevant relationships with ineligible companies to disclose | No |
| Cathy Means, MS | Planner | No relevant relationships with ineligible companies to disclose | No |
| Jennifer Quinn, RN, BSN | Committee Member, Course Director, Speaker | No relevant relationships with ineligible companies to disclose | No |
See individual session information for accreditation information.